Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Visceral leishmaniasis (VL) is a chronic infection, caused by the protozoan parasite Leishmania donovani and L. infantum,
transmitted through the bite of female phlebotomine sand flies. VL is endemic in more than 60 countries, around 59,000
deaths, with 200 million people at risk, 90% of the 500,000 cases per year happen in six countries: India, Bangladesh, Nepal,
Sudan, Brazil and Ethiopia. All recommended treatments have several limitations including high toxicity, resistance issues,
prohibitive prices, long treatment length or inadequate mode of administration. Moreover, there are no effective vaccines to
prevent leishmaniasis. Therefore, the development of new antileishmanial agent with improved pharmacological properties is
imperative.
Licochalcone A isolated from Chinese licorice roots efficiently inhibits proliferation of L. donovani and L. major
promastigotes and amastigotes in vitro by inhibiting fumarate reductase, a selective target present in the parasite mitochondria. In
continuation of our antileishmanial drug discovery program and based on our earlier findings, we synthesized the large number
of chromenochalcones analogues using pyridine-catalyzed Claisen-Schmidt condensation reaction. All the 44 synthesized
compounds were tested in vitro against intramacrophagic amastigotes of L. donovani. Amongst all, twenty two compounds
displayed promising antiamastigote activity with IC
50
ranging from 0.75 to7.66 μg/ml. Most of the compounds displayed better
in vitro activity compared to the existing antileishmanials, sodium antimony gluconate (SAG) and miltefosine in respect to IC
50
and selectivity indices (SI). Compound 7 identified as a most active analogue exhibited significant in vivo inhibition of 84.74% in
L.donovani/ hamster model, and provided a new structural scaffold for novel antileishmanials.
Biography
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals